Chhattisgarh Congress leader Ramdayal Uike joins BJP in Amit Shah's presence

Agencies
October 13, 2018

Bilaspur, Oct 13: In a major setback to the opposition Congress in poll-bound Chhattisgarh, its state working president and MLA Ramdayal Uike Saturday joined the ruling Bharatiya Janata Party.

Mr. Uike, who represents Pali-Tanakhar constituency, joined the BJP in the presence of the party chief Amit Shah and Chief Minister Raman Singh in Bilaspur district headquarter.

Mr. Uike, considered a popular tribal leader in Bilaspur division, said he was feeling suffocated in the Congress as Scheduled Tribes (ST) leaders were being neglected by the party leadership.

In a press conference held in Bilaspur in the presence of the Chief Minister as well BJP state unit president Dharamlal Kaushik, he announced that he joined the BJP.

‘CD politics of Congress’

“I had been feeling suffocated in Congress for the last several years. Congress has diverted from its ideology and principles. The CD politics of Congress has tarnished its image. State Congress chief Bhupesh Baghel has maligned the image of the party by encouraging the obscene CD politics,” he said.

Mr. Uike was apparently referring to a case of circulation of a ‘sex CD’ purportedly featuring a State Minister, in which Mr. Baghel was named as one of the five accused.

He further said his party high command did not pay attention to his demand to remove Mr. Baghel from the post of state unit president.

“Congress has neglected the interests of tribals, backward and poor people and I was pained over it as I represent a tribal region.

“CM Raman Singh has been making efforts for overall development of tribals and backward people and his development oriented policies have impressed me to rejoin my home party,” he said.

“A ghar wapsi”

Mr. Uike, who had quit the BJP and joined the Congress in 2000, described his return to the ruling party as “ghar wapsi”.

When asked about contesting elections, he said he will follow the directions of the party leadership in this regard.

Reacting to the development, Congress dubbed Mr. Uike as an “opportunist” and said his decision will not harm the opposition party.

“Mr. Uike has gone back to BJP, which he had left earlier for opportunistic reasons. He has again proved that he is an opportunist,” Congress state communication wing chief Shailesh Nitin Trivedi said.

No harm to party, says Congress

“His decision is not going to harm Congress in any way as history is witness that the party in which Mr. Uike was there it had never won. In fact we are thankful to Mr. Uike that he has left our party and ensured victory to us,” Mr. Trivedi said.

After the formation of Chhattisgarh in 2000, Mr. Uike who was a BJP MLA from Marwahi seat had joined Congress and vacated his seat to facilitate the entry of Ajit Jogi into the Chhattisgarh Legislative Assembly after he was sworn-in as first Chief Minister of Chhattisgarh.

According to BJP sources, Mr. Uike was not happy after he was ousted from the Congress screening committee and since then he had been in touch with ruling party leadership.

The BJP may field Mr. Uike either from Marwahi or Pali Tanakhar — the ST reserved seats, both considered as his stronghold.

In the state, 18 naxal-affected constituencies will go to polls in the first phase on November 12, while the rest of the 72 constituencies would go to polls in the second phase on November 20.

Comments

Fairman
 - 
Saturday, 13 Oct 2018

Thanks God, dirty things are removed.

 

BJP is built with wrong, ideology and how can it longlast. It can last only until fools around them are in majaority.

Congress should do TIT for TAT.

Sharafat for Shareefs only. It wont work with dishonest people.

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 26,2020

New Delhi, Mar 26: Ujjwala beneficiaries will get free gas cylinders (LPG cylinders) in the next three months, Finance Minister Nirmala Sitharaman announced on Thursday. Addressing a press briefing amid coronavirus pandemic, the finance minister said the announcement is set to benefit 8.3 crore BPL families. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 31,2020

Thiruvananthapuram, Mar 31: Kerala Chief

Minister Pinarayi Vijayan on Tuesday said the government has collected the details of those who took part from the state in recent religious congregations in Nizamuddin and Malaysia and it needs to be examined if they have any health issues.

"Police have already made detailed examination in this regard. Thelist of participants have been given through respectivedistrictcollectors. Necessary precautions will be made in the concerned districts in this regard," Vijayan told reporters here.

The government has the exact number of participants and thedetails of the districts they are hailing from, he said.

Meanwhile, Pathananthitta police said they have identified 6 persons in the district in connection with the Nizamuddin congregation.

"Three persons had taken part in the congregation, of them one hadalready died. One person is in quarantine in the district while theother is located now in Thiruvananrhapuram," a senior police officialtold PTI.

The others are not participants but had travelled to Delhi along with them, he said.

In the nearby Alappuzha district, three persons have been identified in connection with the congregation, police said.

"They have been in quarantine and under the surveillance of thehealth department since they have reached back the state from Delhi," another official said.

Several people, who had attended the religious congregation at Nizamuddin in the national capital are suspected to be having symptoms of Covid19, even as at least 24 have tested positive.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.